New Phase 3 Interim Results Support Safety and Efficacy of Diroximel Fumarate in Multiple Sclerosis Diroximel fumarate significantly reduced disease activity in newly diagnosed relapsing multiple sclerosis (MS) patients and those previously treated with interferons or glatiramer acetate Data show...

Andes Technology Strengthens the RISC-V EasyStart Alliance to 15 ASIC Design Service Partners Hsinchu, Taiwan , March 18, 2019 (GLOBE NEWSWIRE) -- As the first public CPU IP company in Asia, specializing in low-power, high-performance 32/64-bit processor IP cores and SoC design platform,...